K. Kryeziu
发表
C. Pirker,
W. Berger,
B. Döme,
2016,
Molecular Cancer Therapeutics.
V. M. Jerkovic,
D. Georg,
D. Popović,
2016,
EJNMMI Research.
R. Lothe,
R. Dienstmann,
T. Pellinen,
2020,
Clinical Cancer Research.
R. Lothe,
T. Guren,
K. Kryeziu,
2019,
Biochimica et biophysica acta. Reviews on cancer.
W. Berger,
G. Hermann,
G. Koellensperger,
2014
.
W. Berger,
M. A. Hoda,
P. Heffeter,
2013,
Molecular Cancer Therapeutics.
W. Berger,
W. Körner,
I. Turel,
2015,
Journal of medicinal chemistry.
W. Berger,
B. Keppler,
W. Körner,
2016,
Macromolecular bioscience.
C. Pirker,
T. Mohr,
W. Berger,
2017,
Cancer letters.
R. Lothe,
T. Guren,
K. Kryeziu,
2022,
Biochimica et biophysica acta. Reviews on cancer.
M. Mildner,
E. Tschachler,
M. Grusch,
2017,
Archives of Toxicology.
Water-Soluble, Biocompatible Polyphosphazenes with Controllable and pH-Promoted Degradation Behavior
W. Berger,
P. Heffeter,
K. Kryeziu,
2013,
Journal of polymer science. Part A, Polymer chemistry.
R. Lothe,
O. Kallioniemi,
J. Guinney,
2017,
Clinical Cancer Research.
R. Lothe,
P. W. Eide,
A. Nesbakken,
2020,
EBioMedicine.
W. Berger,
V. Pichler,
P. Heffeter,
2014,
Angewandte Chemie.
K. Kryeziu,
2011
.
C. Pirker,
T. Mohr,
W. Berger,
2016,
Oncotarget.
R. Lothe,
O. Myklebost,
L. Meza-Zepeda,
2021,
Genome medicine.
C. Pirker,
W. Berger,
C. Kuntner,
2017,
Nuclear medicine and biology.
K. Lassen,
R. Lothe,
P. W. Eide,
2021,
Journal of translational medicine.
The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo☆
T. Mohr,
W. Berger,
B. Keppler,
2013,
European journal of cancer.
C. Pirker,
T. Mohr,
W. Berger,
2023,
Cancer letters.
W. Berger,
B. Keppler,
L. Gille,
2014,
Dalton transactions.
W. Berger,
B. Keppler,
P. Heffeter,
2016
.
T. Mohr,
W. Berger,
C. Seger,
2013,
Biochemical pharmacology.
E. Leithe,
A. Brech,
K. Kryeziu,
2023,
Biochimica et biophysica acta. Molecular basis of disease.
M. Mildner,
E. Tschachler,
M. Grusch,
2017,
Archives of Toxicology.
C. Pirker,
T. Mohr,
W. Berger,
2016,
Oncotarget.
W. Berger,
P. Heffeter,
K. Kryeziu,
2013,
Molecular Cancer Therapeutics.
R. Lothe,
A. Nesbakken,
T. Guren,
2022,
EMJ Oncology.
W. Berger,
B. Keppler,
L. Gille,
2014,
Dalton transactions.
C. Pirker,
W. Berger,
C. Kuntner,
2017,
Nuclear medicine and biology.